Cilastatin (CAS 82009-34-5)

Cilastatin, with the CAS number 82009-34-5, is a synthetic compound known primarily for its role in inhibiting the human enzyme dehydropeptidase I (DHP-I). This enzyme is located in the renal brush border membranes and is responsible for the hydrolysis of certain dipeptides. By inhibiting DHP-I, Cilastatin prevents the degradation of these dipeptides, which is a critical aspect of its mechanism of action. This inhibition is particularly notable in research focused on the metabolism and bioavailability of various compounds within the renal system. Cilastatin′s ability to preserve other molecules from enzymatic degradation has made it an essential tool in studies investigating the dynamics of renal metabolism and the mechanisms through which compounds are either preserved or broken down in the kidneys. Furthermore, by blocking the action of DHP-I, Cilastatin helps in the study of kidney function and the role of peptidases in renal health and disease. Researchers utilize this compound to explore how modulation of peptidase activity affects kidney function, providing insights into potential approaches for managing conditions that affect renal pathways. This exploration is vital for understanding the complex balance of enzyme actions in renal physiology and can inform broader biological and biochemical studies.